IDO1 and cancer: Along with antibody‐based immune checkpoint inhibition, small molecule immune modulators also play an important role in modulating the ITM.[20] For instance, inhibitors of IDO‐1[11] have been extensively exploited as a strategy to improve cancer immunotherapy.[21]